首页> 外文期刊>Annals of thoracic and cardiovascular surgery: official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia >Intrapleural analgesia using ropivacaine for postoperative pain relief after minimally invasive thoracoscopic surgery
【24h】

Intrapleural analgesia using ropivacaine for postoperative pain relief after minimally invasive thoracoscopic surgery

机译:微创胸腔镜手术后使用罗哌卡因进行胸膜内镇痛

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: to evaluate the efficacy and safety of intrapleural analgesia (IPA) using ropivacaine after thoracoscopic surgery, compared with thoracic epidural analgesia (TEA) using ropivacaine. Methods: forty patients undergoing thoracoscopic bullectomy for spontaneous pneumothorax were randomly assigned to one of two groups. IPA group (n = 20) received intermittent bolus injection of 0.375% ropivacaine into intrapleural space two times; at the end of operation and one more time as the pain increased. TEA group (n = 20) received continuous epidural analgesia with 0.375% ropivacaine. Transrectal diclofenac was administered as an additional analgesic. Pain was assessed on the basis of additional analgesics requirements and by using a visual analog scale (VAS). Results: the time courses of VAS scores along the postoperative time course were not significantly different (p = 0.175). Consumption of transrectal diclofenac was significantly smaller in IPA group (p = 0.025). No major complications appeared in both groups, and incidence of adverse symptoms was not different. Conclusions: in IPA group, pain was managed with less consumption of additional analgesics. IPA could be one of the good choices after thoracoscopic surgery for its efficacy, safety, and benefit of easy placement of the catheter.
机译:目的:评估胸腔镜手术后使用罗哌卡因进行胸膜内镇痛(IPA)与使用罗哌卡因进行胸膜硬膜外镇痛(TEA)的疗效和安全性。方法:将40例因自发性气胸而接受胸腔镜大牛切除术的患者随机分为两组。 IPA组(n = 20)两次向胸膜腔内间歇性推注0.375%罗哌卡因。在手术结束时,随着疼痛的增加又增加了一次。 TEA组(n = 20)接受持续的硬膜外镇痛,使用0.375%的罗哌卡因。经直肠双氯芬酸作为另一种镇痛药使用。根据其他止痛药要求并使用视觉模拟量表(VAS)评估疼痛。结果:术后时间过程中VAS评分的时间过程无显着差异(p = 0.175)。 IPA组经直肠双氯芬酸的消耗量显着减少(p = 0.025)。两组均未出现重大并发症,不良症状发生率无差异。结论:在IPA组中,通过减少额外的镇痛药的使用来控制疼痛。 IPA由于其有效性,安全性以及易于放置导管的优势,可能是胸腔镜手术后的最佳选择之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号